Clinical Trials
We conduct clinical and epidemiological research focused on vaccines and infectious diseases, including Phase II, III, and IV studies that contribute to global scientific progress and support evidence based public health.
We participate in multinational vaccine studies financially supported by the Gates Foundation, contributing to the development and evaluation of new vaccines.
Our research includes:
- IPV005 — Phase IV (Bangladesh)
- nOPV Development — Phase IV (Dominican Republic, Lithuania, Panama)
- HPV Vaccination Impact Study
- IPV001 — Phase IV (Colombia, Dominican Republic, Guatemala, Panama)
- IPV004 — Phase IV (Dominican Republic, Panama)
- nOPV2 M5 — Phase II (Panama, Armenia)
- nOPV2002 — Phase III (Dominican Republic)
Interview August 2022 Interview with @Ananda Bandyopadhyay, Deputy Director-Polio, Bill and Melinda Gates Foundation.
FIDEC's support of the development and rollout program of the novel oral polio vaccine type 2 (nOPV2).